Regeneron Pharmaceuticals, Inc. (REGN)

771.89 -15.15 (-1.93%) USD  |  NASDAQ  |  Feb 24, 16:00
772.19 +0.30 (+0.04%) After-Hours: 17:11
More

Regeneron Pharmaceuticals Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Gilead Sciences, Inc. --
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. --